SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-246522
Filing Date
2024-10-29
Accepted
2024-10-29 16:05:55
Documents
16
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d895459d8k.htm   iXBRL 8-K 53234
2 EX-3.1 d895459dex31.htm EX-3.1 22200
3 EX-4.1 d895459dex41.htm EX-4.1 291349
4 EX-99.1 d895459dex991.htm EX-99.1 10299
  Complete submission text file 0001193125-24-246522.txt   594837

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dvax-20241028.xsd EX-101.SCH 2852
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20241028_lab.xml EX-101.LAB 18741
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20241028_pre.xml EX-101.PRE 11709
19 EXTRACTED XBRL INSTANCE DOCUMENT d895459d8k_htm.xml XML 3872
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 241405704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)